NO178027C - Analogifremgangsmåte ved fremstilling av forlöpere for anti-inflammatoriske 3-acyl-2-oksindol-1-karboksamider - Google Patents
Analogifremgangsmåte ved fremstilling av forlöpere for anti-inflammatoriske 3-acyl-2-oksindol-1-karboksamiderInfo
- Publication number
- NO178027C NO178027C NO911512A NO911512A NO178027C NO 178027 C NO178027 C NO 178027C NO 911512 A NO911512 A NO 911512A NO 911512 A NO911512 A NO 911512A NO 178027 C NO178027 C NO 178027C
- Authority
- NO
- Norway
- Prior art keywords
- oxindole
- carboxamides
- precursors
- acyl
- inflammatory
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 239000002243 precursor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1988/003658 WO1990004393A1 (en) | 1988-10-18 | 1988-10-18 | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO911512D0 NO911512D0 (no) | 1991-04-17 |
| NO911512L NO911512L (no) | 1991-06-12 |
| NO178027B NO178027B (no) | 1995-10-02 |
| NO178027C true NO178027C (no) | 1996-01-10 |
Family
ID=22208957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO911512A NO178027C (no) | 1988-10-18 | 1991-04-17 | Analogifremgangsmåte ved fremstilling av forlöpere for anti-inflammatoriske 3-acyl-2-oksindol-1-karboksamider |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US5118703A (no) |
| JP (1) | JPH07597B2 (no) |
| KR (1) | KR910007237B1 (no) |
| CN (1) | CN1022241C (no) |
| AP (1) | AP118A (no) |
| AR (1) | AR246519A1 (no) |
| AT (1) | ATE125794T1 (no) |
| AU (1) | AU606819B2 (no) |
| BG (1) | BG50834A3 (no) |
| CA (1) | CA1339558C (no) |
| CZ (1) | CZ278983B6 (no) |
| DD (1) | DD285604A5 (no) |
| DK (1) | DK514989A (no) |
| EG (1) | EG19887A (no) |
| FI (1) | FI95253C (no) |
| HU (1) | HU208421B (no) |
| IE (1) | IE66586B1 (no) |
| IL (1) | IL91960A (no) |
| IS (1) | IS1598B (no) |
| MA (1) | MA21657A1 (no) |
| MX (1) | MX18021A (no) |
| MY (1) | MY104238A (no) |
| NO (1) | NO178027C (no) |
| NZ (1) | NZ231044A (no) |
| OA (1) | OA09140A (no) |
| PH (1) | PH27554A (no) |
| PL (2) | PL162316B1 (no) |
| PT (1) | PT92000B (no) |
| RO (1) | RO109195B1 (no) |
| RU (1) | RU2036905C1 (no) |
| SK (1) | SK278175B6 (no) |
| WO (1) | WO1990004393A1 (no) |
| YU (1) | YU48070B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059693A (en) * | 1989-10-06 | 1991-10-22 | Pfizer Inc. | Process for making 3-aroyl-2-oxindole-1-carboxamides |
| US5648502A (en) * | 1992-11-23 | 1997-07-15 | Pfizer Inc. | Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid |
| US5270331A (en) * | 1993-01-26 | 1993-12-14 | Pfizer, Inc. | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| WO1994018194A1 (en) * | 1993-02-09 | 1994-08-18 | Pfizer Inc. | Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as intiinflammatory agents |
| US5449788A (en) * | 1994-01-28 | 1995-09-12 | Catalytica, Inc. | Process for preparing 2-oxindole-1-carboxamides |
| CN1094819C (zh) * | 1997-04-30 | 2002-11-27 | 大兴株式会社 | 环状坯料之制造装置 |
| EP0984012A3 (en) * | 1998-08-31 | 2001-01-10 | Pfizer Products Inc. | Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties |
| EP1223809A4 (en) * | 1999-10-26 | 2004-03-03 | Univ Texas Southwestern Med Ct | METHODS OF TREATING HAIR LOSS COMPRISING THE ADMINISTRATION OF AN INDOLIN COMPOUND |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL96047C (no) * | 1956-06-08 | |||
| US3564009A (en) * | 1966-01-13 | 1971-02-16 | Sumitomo Chemical Co | Process for producing 1-acylindole derivatives |
| BE756447A (fr) * | 1969-10-15 | 1971-03-22 | Pfizer | Oxindolecarboxamides |
| US3923996A (en) * | 1972-07-31 | 1975-12-02 | Sandoz Ag | 3-Substituted-oxindoles in compositions and methods of treating obesity |
| IE53102B1 (en) * | 1981-05-12 | 1988-06-22 | Ici Plc | Pharmaceutical spiro-succinimide derivatives |
| DE3268971D1 (en) * | 1981-10-06 | 1986-03-20 | Ici Plc | Biochemical process |
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US4752609A (en) * | 1985-06-20 | 1988-06-21 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| US5036099A (en) * | 1987-02-02 | 1991-07-30 | Pfizer Inc. | Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
| ES2075055T3 (es) * | 1988-10-18 | 1995-10-01 | Pfizer | Profarmacos de 3-acil-2-oxindol-1-carboxamidas antiinflamatorias. |
| US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
| US5059693A (en) * | 1989-10-06 | 1991-10-22 | Pfizer Inc. | Process for making 3-aroyl-2-oxindole-1-carboxamides |
-
1988
- 1988-10-18 US US07/675,883 patent/US5118703A/en not_active Expired - Lifetime
- 1988-10-18 WO PCT/US1988/003658 patent/WO1990004393A1/en active IP Right Grant
- 1988-10-18 RO RO147347A patent/RO109195B1/ro unknown
- 1988-10-18 MX MX1802188A patent/MX18021A/es unknown
- 1988-10-18 HU HU886740A patent/HU208421B/hu not_active IP Right Cessation
- 1988-10-18 SK SK5906-89A patent/SK278175B6/sk unknown
-
1989
- 1989-09-20 IS IS3509A patent/IS1598B/is unknown
- 1989-09-28 CA CA000614317A patent/CA1339558C/en not_active Expired - Fee Related
- 1989-10-04 PH PH39329A patent/PH27554A/en unknown
- 1989-10-09 AT AT89310319T patent/ATE125794T1/de active
- 1989-10-12 IL IL9196089A patent/IL91960A/xx not_active IP Right Cessation
- 1989-10-16 BG BG90022A patent/BG50834A3/xx unknown
- 1989-10-16 PT PT92000A patent/PT92000B/pt not_active IP Right Cessation
- 1989-10-16 YU YU200589A patent/YU48070B/sh unknown
- 1989-10-16 AP APAP/P/1989/000141A patent/AP118A/en active
- 1989-10-16 MY MYPI89001415A patent/MY104238A/en unknown
- 1989-10-17 OA OA59665A patent/OA09140A/xx unknown
- 1989-10-17 AU AU42956/89A patent/AU606819B2/en not_active Ceased
- 1989-10-17 NZ NZ231044A patent/NZ231044A/en unknown
- 1989-10-17 AR AR89315179A patent/AR246519A1/es active
- 1989-10-17 PL PL89281871A patent/PL162316B1/pl unknown
- 1989-10-17 JP JP1270174A patent/JPH07597B2/ja not_active Expired - Lifetime
- 1989-10-17 CN CN89107943A patent/CN1022241C/zh not_active Expired - Fee Related
- 1989-10-17 DD DD89333653A patent/DD285604A5/de not_active IP Right Cessation
- 1989-10-17 DK DK514989A patent/DK514989A/da not_active Application Discontinuation
- 1989-10-17 MA MA21909A patent/MA21657A1/fr unknown
- 1989-10-17 KR KR1019890014914A patent/KR910007237B1/ko not_active IP Right Cessation
- 1989-10-17 PL PL89296831A patent/PL163112B1/pl unknown
- 1989-10-17 IE IE333289A patent/IE66586B1/en not_active IP Right Cessation
- 1989-10-18 EG EG49689A patent/EG19887A/xx active
- 1989-10-18 CZ CS895906A patent/CZ278983B6/cs not_active IP Right Cessation
-
1991
- 1991-04-17 FI FI911855A patent/FI95253C/fi not_active IP Right Cessation
- 1991-04-17 RU SU914895525A patent/RU2036905C1/ru active
- 1991-04-17 NO NO911512A patent/NO178027C/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| NO174101C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater | |
| NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
| NO171167C (no) | Analogifremgangsmaate ved fremstilling av cytidin-derivater | |
| NO177525C (no) | FremgangsmÕte for fremstilling av et kombinert anti- inflammatorisk preparat | |
| NO914809D0 (no) | Fremgangsmaate ved fremstilling av celluloseformlegemer | |
| FI872785A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi | |
| FI945441A (fi) | Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi | |
| NO943093D0 (no) | Fremgangsmåte for fremstilling av clavulansyre | |
| NO174604C (no) | Fremgangsmåte ved fremstilling av relief-former | |
| NO175478C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater | |
| NO167912C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aromatiske forbindelser | |
| NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
| FI881064A (fi) | Menetelmä tulehduksenvastaisten tai analgeettisten -aminoetyylisubstituoitujen fenyyliyhdisteiden valmistamiseksi | |
| NO177496C (no) | Fremgangsmåte ved fremstilling av mono-N-alkylerte polyazamakrocykler | |
| NO178027C (no) | Analogifremgangsmåte ved fremstilling av forlöpere for anti-inflammatoriske 3-acyl-2-oksindol-1-karboksamider | |
| NO178698C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
| NO174774C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner | |
| NO175476C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive cykloalkyltiazolderinvater | |
| NO304883B1 (no) | FremgangsmÕte ved fremstilling av hydrazin-nitroform | |
| NO304150B1 (no) | FremgangsmÕte ved fremstilling av et alkylbenzen | |
| NO176565C (no) | Analogifremgangsmåte for fremstilling av antitrombotisk aktive forbindelser | |
| NO951808D0 (no) | Fremgangsmåte ved fremstilling av enatiomert rene triazolylbenzotriazoler | |
| FI91069B (fi) | Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi |